ERBB2 and breast cancer: Evidence also indicates that Notch crosstalks with other oncogenic pathways involved in BC carcinogenesis, such as those mediated by developmental signals (e.g., Wnt), growth factors (e.g., VEGFR), cytokines, receptors (e.g., ER, HER2) and oncogenic kinases (e.g., MAPK).